8-K current report · filed Nov 20, 2026

Insulet Corporation (PODD) 8-K Current Report: November 20, 2026

Item 5.02PODD overview

Short answer

Insulet Corporation (PODD) filed an 8-K current report with the SEC on November 20, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Michael R. Minogue reappointed as Class I director effective November 20, 2026, term through 2029 annual meeting.

Insulet Corporation 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Michael R. Minogue reappointed as Class I director effective November 20, 2026, term through 2029 annual meeting
  • Return restores prior healthcare leadership and medtech expertise following September 2026 resignation
  • Former Abiomed chairman and CEO through its December 2022 sale, adding medical-device operating experience
  • Approximately $121,700 restricted stock unit grant, representing prorated portion of $260,000 annual equity award
  • Additional cash compensation under Insulet’s non-employee director program

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Insulet Corporation 8-K filings

Get the next PODD 8-K as it lands

Follow PODD for push alerts, or ask the research agent what this filing means.